down arrow

Viva Biotech Holdings

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG9390W1015
HKD
1.94
0.05 (2.65%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
3SBio, Inc.
Viva Biotech Holdings
Alphamab Oncology
Frontage Holdings Corp.
Jacobio Pharmaceuticals Group Co., Ltd.
Sirnaomics Ltd.
CanSino Biologics, Inc.
Beijing Lüzhu Biotechnology Co., Ltd.
Laekna, Inc.
Ascentage Pharma Group International Co., Ltd.
AIM Vaccine Co., Ltd.
Why is Viva Biotech Holdings ?
1
High Debt company with Weak Long Term Fundamental Strength
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 1.66% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 24
  • RAW MATERIAL COST(Y) Grown by 6.6% (YoY)
  • CASH AND EQV(HY) Lowest at HKD 1,031.51 MM
  • DEBTORS TURNOVER RATIO(HY) Lowest at 3.8%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Viva Biotech Holdings for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Viva Biotech Holdings
108.6%
2.76
88.33%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
36.46%
EBIT Growth (5y)
29.19%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
2.22
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.33
Tax Ratio
24.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
4.47%
ROE (avg)
1.66%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.42
EV to EBIT
24.32
EV to EBITDA
12.60
EV to Capital Employed
1.39
EV to Sales
2.81
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
5.72%
ROE (Latest)
4.24%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Viva Biotech Holdings
Pre-Tax Profit
At HKD 98.7 MM has Grown at 1,210.67%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit
At HKD 39.99 MM has Grown at 213.39%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (HKD MM)

Operating Cash Flow
Highest at HKD 739.71 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Debt-Equity Ratio
Lowest at 8.28 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Operating Profit Margin
Highest at 22.4 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Depreciation
Highest at HKD 121.78 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 121.78 MM has Grown at 10.61%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Viva Biotech Holdings
Cash and Eqv
Lowest at HKD 1,031.51 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio
Lowest at 3.8%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 6.6% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."